These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1598872

  • 1. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
    Regitz V, Fleck E.
    Am J Cardiol; 1992 Jun 15; 69(19):1574-80. PubMed ID: 1598872
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul 15; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
    Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GA, Lackner K.
    Circulation; 1992 Dec 15; 86(6):1810-8. PubMed ID: 1451253
    [Abstract] [Full Text] [Related]

  • 10. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy.
    Schultheiss HP.
    Basic Res Cardiol; 1992 Dec 15; 87 Suppl 1():311-20. PubMed ID: 1497575
    [Abstract] [Full Text] [Related]

  • 11. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
    Kalsi KK, Smolenski RT, Pritchard RD, Khaghani A, Seymour AM, Yacoub MH.
    Eur J Clin Invest; 1999 Jun 15; 29(6):469-77. PubMed ID: 10354207
    [Abstract] [Full Text] [Related]

  • 12. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy.
    Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR.
    Circ Res; 1992 Jul 15; 71(1):18-26. PubMed ID: 1318794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adenine nucleotide content in cold preserved human donor hearts and subsequent cardiac performance after orthotopic heart transplantation.
    Starling RC, Hammer DF, Binkley PF, Galbraith TA, Howanitz EP, Murray KD, Watson KM, Myerowitz PD.
    J Heart Lung Transplant; 1991 Jul 15; 10(4):508-16; discussion 517. PubMed ID: 1911793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study.
    Kawai C, Yui Y, Hoshino T, Sasayama S, Matsumori A.
    J Am Coll Cardiol; 1983 Nov 15; 2(5):834-40. PubMed ID: 6685149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nucleotide metabolism and cellular damage in myocardial ischemia.
    Jennings RB, Steenbergen C.
    Annu Rev Physiol; 1985 Nov 15; 47():727-49. PubMed ID: 2581508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.